207 related articles for article (PubMed ID: 15197336)
21. The role of STATs in transcriptional control and their impact on cellular function.
Bromberg J; Darnell JE
Oncogene; 2000 May; 19(21):2468-73. PubMed ID: 10851045
[TBL] [Abstract][Full Text] [Related]
22. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.
Smith ND; Rubenstein JN; Eggener SE; Kozlowski JM
J Urol; 2003 Apr; 169(4):1219-28. PubMed ID: 12629332
[TBL] [Abstract][Full Text] [Related]
23. The E2F family and the role of E2F1 in apoptosis.
Wu Z; Zheng S; Yu Q
Int J Biochem Cell Biol; 2009 Dec; 41(12):2389-97. PubMed ID: 19539777
[TBL] [Abstract][Full Text] [Related]
24. Cancer stem cells and markers: new model of tumorigenesis with therapeutic implications.
Natarajan TG; Ganesan N; Fitzgerald KT
Cancer Biomark; 2010; 9(1-6):65-99. PubMed ID: 22112470
[TBL] [Abstract][Full Text] [Related]
25. Biology of Krüppel-like factor 6 transcriptional regulator in cell life and death.
Andreoli V; Gehrau RC; Bocco JL
IUBMB Life; 2010 Dec; 62(12):896-905. PubMed ID: 21154818
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance.
Wilting RH; Dannenberg JH
Drug Resist Updat; 2012; 15(1-2):21-38. PubMed ID: 22356866
[TBL] [Abstract][Full Text] [Related]
27. Regulation of pro-apoptotic BH3-only proteins and its contribution to cancer progression and chemoresistance.
Fernandez-Luna JL
Cell Signal; 2008 Nov; 20(11):1921-6. PubMed ID: 18555662
[TBL] [Abstract][Full Text] [Related]
28. SV40 T/t-common polypeptide specifically induces apoptosis in human cancer cells that overexpress HER2/neu.
Wen CC; Cheng SA; Hsuen SP; Huang YL; Kuo ZK; Lee HF; Kuo CH; Du JL; Wang WB
Cancer Res; 2006 Jun; 66(11):5847-57. PubMed ID: 16740724
[TBL] [Abstract][Full Text] [Related]
29. An ordinary differential equation model for the multistep transformation to cancer.
Spencer SL; Berryman MJ; García JA; Abbott D
J Theor Biol; 2004 Dec; 231(4):515-24. PubMed ID: 15488528
[TBL] [Abstract][Full Text] [Related]
30. Opposed arsenite-mediated regulation of p53-survivin is involved in neoplastic transformation, DNA damage, or apoptosis in human keratinocytes.
Li Y; Jiang R; Zhao Y; Xu Y; Ling M; Pang Y; Shen L; Zhou Y; Zhang J; Zhou J; Wang X; Liu Q
Toxicology; 2012 Oct; 300(3):121-31. PubMed ID: 22706169
[TBL] [Abstract][Full Text] [Related]
31. Cellular senescence: a double-edged sword in the fight against cancer.
Ohtani N; Takahashi A; Mann DJ; Hara E
Exp Dermatol; 2012 Jul; 21 Suppl 1():1-4. PubMed ID: 22626462
[TBL] [Abstract][Full Text] [Related]
32. Implications of apoptotic cell death regulation in cancer therapy.
McDonnell TJ; Meyn RE; Robertson LE
Semin Cancer Biol; 1995 Feb; 6(1):53-60. PubMed ID: 7548842
[TBL] [Abstract][Full Text] [Related]
33. TLR signaling by tumor and immune cells: a double-edged sword.
Huang B; Zhao J; Unkeless JC; Feng ZH; Xiong H
Oncogene; 2008 Jan; 27(2):218-24. PubMed ID: 18176603
[TBL] [Abstract][Full Text] [Related]
34. Angiogenesis and apoptosis are cellular parameters of neoplastic progression in transgenic mouse models of tumorigenesis.
Bergers G; Hanahan D; Coussens LM
Int J Dev Biol; 1998; 42(7):995-1002. PubMed ID: 9853830
[TBL] [Abstract][Full Text] [Related]
35. Modification of gene products involved in resistance to apoptosis in metastatic colon cancer cells: roles of Fas, Apaf-1, NFkappaB, IAPs, Smac/DIABLO, and AIF.
Huerta S; Heinzerling JH; Anguiano-Hernandez YM; Huerta-Yepez S; Lin J; Chen D; Bonavida B; Livingston EH
J Surg Res; 2007 Sep; 142(1):184-94. PubMed ID: 17603079
[TBL] [Abstract][Full Text] [Related]
36. Death receptors in chemotherapy and cancer.
Debatin KM; Krammer PH
Oncogene; 2004 Apr; 23(16):2950-66. PubMed ID: 15077156
[TBL] [Abstract][Full Text] [Related]
37. Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation.
Woo RA; Poon RY
Genes Dev; 2004 Jun; 18(11):1317-30. PubMed ID: 15175263
[TBL] [Abstract][Full Text] [Related]
38. Back to the beginning: The initiation of cancer.
Cobaleda C; Sánchez-García I
Bioessays; 2013 May; 35(5):413. PubMed ID: 23553938
[No Abstract] [Full Text] [Related]
39. Abnormalities of cell structures in tumors: apoptosis in tumors.
Cheung HH; Arora V; Korneluk RG
EXS; 2006; (96):201-21. PubMed ID: 16383020
[TBL] [Abstract][Full Text] [Related]
40. Changing mutational and adaptive landscapes and the genesis of cancer.
Liggett LA; DeGregori J
Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):84-94. PubMed ID: 28167050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
